More importantly, YY1 expression was reduced by Silibinin in vivo, and its overexpression enhanced SLC1A5 expression in Silibinin-induced GBM cells, confirming that Silibinin suppressed SLC1A5 expression by regulating YY1. The gene discussed is SLC1A5; the disease is glioblastoma.